Book an appointment

🇮🇩 From Indonesia · Hepatology · Infectious disease

Hepatitis B treatment in China for Indonesia patients

End-to-end pathway: visa, flight, hospital match, cost and length of stay — tailored for patients travelling from Indonesia for hepatitis b care.

← Full Hepatitis B guide

Pathway at a glance

Visa
M-Visa (Visa Medis)
Processing
5–7 business days
Flight
5–6 hours (CGK/SUB to CAN/HKG)
Time zone
1 hour ahead (Jakarta → Beijing)
Language
Indonesian-speaking coordinators available at HKU-Shenzhen, Guangzhou international departments and Shanghai United Family on advance request

About hepatitis b

Chronic hepatitis B (CHB) affects approximately 296 million people globally per WHO estimates and remains one of the leading causes of cirrhosis and hepatocellular carcinoma. Modern nucleos(t)ide analogue therapy — entecavir, tenofovir disoproxil (TDF), and tenofovir alafenamide (TAF) — suppresses HBV DNA to undetectable in over 95% of treatment-naive patients, dramatically reducing long-term liver and cancer risk.

The barrier outside Class A Chinese care is rarely the medicine itself. It is the price. China has the most economical access to modern HBV antiviral therapy globally, with structured hepatology infrastructure to support both initial workup and long-term monitoring.

Why Indonesia patients travel to China

Indonesian patients commonly come for: nasopharyngeal carcinoma (Indonesia has high regional NPC prevalence; SYSU Guangzhou is global #1), cardiac surgery, stem cell therapy, orthopedic, fertility / IVF. Halal arrangements similar to Saudi/UAE.

Recommended cities for Indonesia patients

Guangzhou (SYSU Cancer Center for NPC and head & neck — particularly relevant for Indonesian patients given regional NPC prevalence), Shenzhen (cellular therapy, dental, English-first), Shanghai for premium cases.

Diagnostic workup at Class A centres

  • HBsAg + anti-HBs + anti-HBc (initial 3-marker panel)
  • If HBsAg positive: HBeAg + anti-HBe, HBV DNA quantitation
  • ALT, AST, GGT, complete metabolic panel, alpha-fetoprotein (HCC screening)
  • Abdominal ultrasound + FibroScan transient elastography for fibrosis staging
  • Hepatology consultation with structured treatment plan

Workup cost band: $200–$340 USD.

Treatment options

Tenofovir alafenamide (TAF / Vemlidy)

first-line

Modern oral antiviral with excellent bone and renal safety profile. China price: USD 15–30/month vs USD 1,400–1,800/month US.

Learn more →

Tenofovir disoproxil (TDF, generic)

first-line

Long-established first-line option. Generic available widely. China price: USD 5–15/month.

Learn more →

Entecavir (generic)

first-line

Alternative first-line nucleoside analogue. China price: USD 8–20/month.

Pegylated interferon alfa-2a

selected cases

Finite 48-week course; appropriate for selected HBeAg-positive patients with elevated ALT and low HBV DNA. Higher rate of HBsAg loss but more side effects than oral antivirals.

Liver transplant

advanced disease

Indicated for decompensated cirrhosis or HCC within criteria. Tianjin First Center, Renji, and major Beijing centres run high-volume programmes.

Learn more →

Visa pathway for Indonesia patients

Strong demand growth from Indonesia given limited domestic specialty depth. Direct flights to Guangzhou, Shenzhen, Hong Kong make South China most accessible.

  1. 1

    Receive invitation letter

    Panda Touring Care issues invitation letter within 3–5 business days.

  2. 2

    Complete COVA online

    cova.cs.mfa.gov.cn online application.

  3. 3

    Submit at CVASC

    Jakarta, Surabaya, Medan, or Denpasar visa centre with biometrics.

  4. 4

    Collect visa

    5–7 business days.

Full Indonesia → China visa guide →

Frequently asked

Do Indonesia patients need a visa for hepatitis b treatment in China?
Yes — Indonesia citizens require M-Visa for medical treatment in China. Processing: 5–7 business days. Fee: IDR 800,000–1,500,000. Validity: Up to 2 years multi-entry possible.
How long is the flight from Indonesia to China?
5–6 hours (CGK/SUB to CAN/HKG)
Which Chinese cities are best for Indonesia patients seeking hepatitis b care?
Guangzhou (SYSU Cancer Center for NPC and head & neck — particularly relevant for Indonesian patients given regional NPC prevalence), Shenzhen (cellular therapy, dental, English-first), Shanghai for premium cases.
What's the diagnostic workup for hepatitis b at Class A international departments?
HBsAg + anti-HBs + anti-HBc (initial 3-marker panel); If HBsAg positive: HBeAg + anti-HBe, HBV DNA quantitation; ALT, AST, GGT, complete metabolic panel, alpha-fetoprotein (HCC screening); Abdominal ultrasound + FibroScan transient elastography for fibrosis staging; Hepatology consultation with structured treatment plan.

Plan your hepatitis b treatment from Indonesia

We arrange visa support, hospital match, written quote and door-to-door logistics from Indonesia. No obligation.

Request a quote Visa details